Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
MMWR Morb Mortal Wkly Rep ; 63(46): 1072-6, 2014 Nov 21.
Article in English | MEDLINE | ID: mdl-25412066

ABSTRACT

The epidemic of Ebola virus disease (Ebola) in West Africa that began in March 2014 has caused approximately 13,200 suspected, probable, and confirmed cases, including approximately 6,500 in Liberia. About 50% of Liberia's reported cases have been in Montserrado County (population 1.5 million), the most populous county, which contains the capital city, Monrovia. To examine the course of the Ebola epidemic in Montserrado County, data on Ebola treatment unit (ETU) admissions, laboratory testing of patient blood samples, and collection of dead bodies were analyzed. Each of the three data sources indicated consistent declines of 53%-73% following a peak incidence in mid-September. The declines in ETU admissions, percentage of patients with reverse transcription-polymerase chain reaction (RT-PCR) test results positive for Ebola, and dead bodies are the first evidence of reduction in disease after implementation of multiple prevention and response measures. The possible contributions of these interventions to the decline is not yet fully understood or corroborated. A reduction in cases suggests some progress; however, eliminating Ebola transmission is the critical goal and will require greatly intensified efforts for complete, high-quality surveillance to direct and drive the rapid intervention, tracking, and response efforts that remain essential.


Subject(s)
Ebolavirus/isolation & purification , Epidemics/prevention & control , Hemorrhagic Fever, Ebola/prevention & control , Patient Admission/statistics & numerical data , Hemorrhagic Fever, Ebola/epidemiology , Humans , Liberia/epidemiology
2.
MMWR Morb Mortal Wkly Rep ; 63(46): 1082-6, 2014 Nov 21.
Article in English | MEDLINE | ID: mdl-25412068

ABSTRACT

On March 21, 2014, the Guinea Ministry of Health reported the outbreak of an illness characterized by fever, severe diarrhea, vomiting and a high fatality rate (59%), leading to the first known epidemic of Ebola virus disease (Ebola) in West Africa and the largest and longest Ebola epidemic in history. As of November 2, Liberia had reported the largest number of cases (6,525) and deaths (2,697) among the three affected countries of West Africa with ongoing transmission (Guinea, Liberia, and Sierra Leone). The response strategy in Liberia has included management of the epidemic through an incident management system (IMS) in which the activities of all partners are coordinated. Within the IMS, key strategies for epidemic control include surveillance, case investigation, laboratory confirmation, contact tracing, safe transportation of persons with suspected Ebola, isolation, infection control within the health care system, community engagement, and safe burial. This report provides a brief overview of the progression of the epidemic in Liberia and summarizes the interventions implemented.


Subject(s)
Epidemics/prevention & control , Hemorrhagic Fever, Ebola/epidemiology , Ebolavirus/isolation & purification , Humans , Liberia/epidemiology , Patient Admission/statistics & numerical data
3.
Vaccine ; 26(52): 6980-5, 2008 Dec 09.
Article in English | MEDLINE | ID: mdl-18805455

ABSTRACT

The WHO European Region has a measles elimination target for 2010. Between September 2005 and mid-June 2006, more than 50,000 measles cases were reported in Ukraine; many reportedly had received two doses of measles vaccine and over 60% were among persons 15-29 years old. To investigate vaccine effectiveness (VE), a case-control study was undertaken in Dnepropetrovsk region. VE for two doses of measles vaccine was 93.1%, providing insufficient population immunity for measles elimination. An additional dose of measles vaccine for these age-cohorts is required if Ukraine is to achieve measles elimination. Other republics of the former Soviet Union also need to consider a supplemental dose of measles vaccine for older age groups identified epidemiologically to be at increased risk for measles even though individuals may have already received two doses.


Subject(s)
Measles Vaccine/immunology , Measles/epidemiology , Measles/immunology , Adolescent , Adult , Case-Control Studies , Cohort Studies , Data Interpretation, Statistical , Disease Outbreaks , Humans , Immunization Programs , Population Surveillance , Sample Size , Treatment Failure , Ukraine/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...